Prime Capital Investment Advisors’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.9K | Sell |
37,993
-15,986
| -30% | -$20.1K | ﹤0.01% | 926 |
|
|
2025
Q1 | $49.3K | Sell |
53,979
-1,783
| -3% | -$1.63K | ﹤0.01% | 1024 |
|
|
2024
Q4 | $88.7K | Buy |
55,762
+40,291
| +260% | +$64.1K | ﹤0.01% | 897 |
|
|
2024
Q3 | $30.3K | Sell |
15,471
-547
| -3% | -$1.07K | ﹤0.01% | 900 |
|
|
2024
Q2 | $26.3K | Sell |
16,018
-292
| -2% | -$479 | ﹤0.01% | 906 |
|
|
2024
Q1 | $83.8K | Sell |
16,310
-1,366
| -8% | -$7.02K | ﹤0.01% | 963 |
|
|
2023
Q4 | $101K | Sell |
17,676
-18,787
| -52% | -$108K | ﹤0.01% | 910 |
|
|
2023
Q3 | $174K | Sell |
36,463
-3,854
| -10% | -$18.4K | ﹤0.01% | 698 |
|
|
2023
Q2 | $171K | Buy |
40,317
+13,986
| +53% | +$59.4K | ﹤0.01% | 715 |
|
|
2023
Q1 | $140K | Buy |
+26,331
| New | +$140K | 0.01% | 519 |
|